Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
The Fly
Altimmune announces new analyses at EASL on MASH Resolution Index
4d ago
ALT
Premium
Pre-Earnings
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
ALT
Premium
The Fly
Altimmune management to meet with Piper Sandler
1M ago
ALT
Premium
Ratings
Altimmune’s Pemvidutide: A Promising Catalyst with Blockbuster Potential and Strong Financial Backing
1M ago
ALT
Premium
Ratings
Altimmune’s Strategic Positioning and Promising Future in Obesity and MASH Treatment Markets
2M ago
ALT
Premium
Ratings
Altimmune’s Pemvidutide: A Promising Best-in-Class Therapy with Broad Potential and Strong Buy Rating
2M ago
ALT
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ALT
CLLS
Premium
The Fly
Altimmune call volume above normal and directionally bullish
2M ago
ALT
Premium
Ratings
Altimmune’s Promising R&D Developments and Market Opportunities Drive Buy Rating
2M ago
ALT
Premium
The Fly
Altimmune call volume above normal and directionally bullish
2M ago
ALT
Premium
The Fly
Evercore bullish on Altimmune, likes drug move into alcohol related disease
2M ago
ALT
Premium
Ratings
Promising Potential of Altimmune’s Pemvidutide Drives Buy Rating Amid Expanding Indications and Strong Market Outlook
2M ago
ALT
Premium
Ratings
Altimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion
2M ago
ALT
Premium
Company Announcements
Altimmune’s Earnings Call: Progress Amid Challenges
2M ago
ALT
Premium
Company Announcements
Altimmune Reports Progress in Clinical Trials and Financials
2M ago
ALT
Premium
The Fly
Altimmune initiated with a Market Perform at William Blair
2M ago
ALT
Premium
The Fly
Altimmune files $400M mixed securities shelf
2M ago
ALT
Premium
Ratings
Altimmune’s Innovative Approach to MASH and Obesity: A Promising Future with Pemvidutide
2M ago
ALT
Premium
Company Announcements
Altimmune Reports 2024 Financial Results and R&D Progress
2M ago
8K
ALT
Premium
The Fly
Altimmune reports Q4 EPS (33c), consensus (34c)
2M ago
ALT
Premium
Company Announcements
Altimmune Expands Board Amid Late-Stage Drug Development
3M ago
8K
ALT
Premium
The Fly
Altimmune appoints Teri Lawver, Jerry Durso to board
3M ago
ALT
DXCM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
